Anika Therapeutics ANIK Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$11.17M+80.2% | -$56.39M+31.8% | -$82.67M-456% | -$14.86M— | ||
| $5.37M-22.0% | $6.88M+7.0% | $6.43M-4.0% | $6.7M+3.5% | ||
| $10.08M-23.2% | $13.13M-13.9% | $15.24M+6.5% | $14.32M+29.1% | ||
| $11.19M+107% | $5.4M— | —— | $4.41M-47.5% | ||
| $6.83M-11.7% | $7.73M+42.5% | $5.43M-27.5% | $7.49M+45.6% | ||
| —— | -$8.33M-53.6% | -$5.43M+27.5% | -$7.49M-140% | ||
| —— | $10.91M+118% | $5M— | —— | ||
| -$10.73M+15.7% | -$12.73M-91.0% | -$6.67M— | —— | ||
| —— | -$15.71M— | —— | —— | ||
| $4.36M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Anika Therapeutics generate?
- Anika Therapeutics (ANIK) generated $6.5M in operating cash flow over the trailing twelve months.
- What is Anika Therapeutics's free cash flow?
- After $5.4M of capital expenditures, Anika Therapeutics's free cash flow was $1.0M over the trailing twelve months, up 105.4% year over year.
- Where does Anika Therapeutics's cash flow data come from?
- Every line is extracted from Anika Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
